EUVIMEDEUVIMED entdecken
Crossref

Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Corticotroph Pituitary Neuroendocrine Tumors

Spencer Raub, Thomas Hanks, Jessica Eaton, Evgeniya Tyrtova, Zirun Zhao, Norman Garrett III, Racheal Peterson, Gabriel Zada, Samuel Emerson, Manuel Ferreira, Jacob Ruzevick

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Spencer Raub und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Silent corticotroph pituitary neuroendocrine tumors (SC PitNET) represent a subset of nonfunctional PitNETs that exhibit positive immunostaining for adrenocorticotropic hormone (ACTH) and constitute 20% of all nonfunctional PitNETs. SC PitNETs exhibit more aggressive behavior, higher recurrence rates, and poor response to repeated intervention as compared to other nonfunctional PitNETs. While modern diagnostics utilize lineage specific transcription factors for PitNET diagnosis, their implementation is recent in most clinical labs and thus a more thorough evaluation of the behavior and outcomes of SC PitNETs, as defined by hormone staining, is beneficial to inform individualized treatment strategies.

Objective

To evaluate a multicenter surgical series of SC PitNETs to characterize the behavior, clinical outcomes, and treatment strategies of SC PitNETs, especially those experiencing tumor recurrence/progression.

Methods

A multi-center, multi-surgeon retrospective clinical study of 1,475 patients who underwent resection of PitNETs at the University of Washington and University of Southern California between 2011 and 2023 was performed. Patients were selected based on pathologic confirmation of ACTH expression by immunohistochemistry. Patients with Cushing’s disease were excluded. Demographic information, preoperative radiographic characteristics, tumor pathology characteristics, and surgical and radiographic outcomes were studied. Additional treatment details were collected for those patients who experienced tumor recurrence/progression. Progression/recurrence was visualized using Kaplan–Meier analysis. Individual patient data was visualized using a swimmers plot.

Results

A total of 277 patients were identified with positive immunohistochemical staining for ACTH on tumor pathology. Excluding patients with Cushing’s Disease yielded a total of 186 patients. The average age was 52.3 ± 14.5 years and 61.3% of patients were women. A total of 113 tumors (60.8%) immunostained for ACTH only while 73 (39.2%) had positive IHC staining for additional hormone/s. Radiographically, there was a substantial rate of extrasellar growth including suprasellar (63.7%), cavernous sinus (56.4%), and clival/sphenoid (12.3%) invasion. At the time of the index surgery at each institution, most were treated via the endoscopic endonasal approach (96.2%). Gross total resection was achieved in 79.7% of cases. Of those that achieved GTR, a total of 18 (12.7%) experienced tumor recurrence. Of those patients experiencing STR, a total of 6 (16.7%) experienced tumor progression. Of patients experiencing recurrence/progression, 29.2% underwent additional surgery and 20.8% underwent additional surgery and radiation. Overall, the recurrence/progression free survival at mean follow-up time of 21.5 months was 85.9%, and 55.6% after 5 years ([ Fig. 1 ]). A swimmers plot visualizing individual patient follow-up duration, recurrence/progression status, and additional treatment details is shown in [ Fig. 2 ].

Conclusion

SC PitNETs exhibit an aggressive clinical phenotype, with potential early and frequent recurrence. Long-term clinical and radiographic follow-up is recommended as recurrence/progression often requires additional surgery and/or radiosurgery for tumor control. Fig. 1 Fig. 2 Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Raub, S., Hanks, T., Eaton, J., Tyrtova, E., Zhao, Z., III, N. G., Peterson, R., Zada, G., Emerson, S., Ferreira, M., & Ruzevick, J. (2024). Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Corticotroph Pituitary Neuroendocrine Tumors. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779925

Vancouver

Raub S, Hanks T, Eaton J, Tyrtova E, Zhao Z, III NG, et al. Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Corticotroph Pituitary Neuroendocrine Tumors. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779925

BibTeX
@article{Raub2024,
  author = {Raub, Spencer and Hanks, Thomas and Eaton, Jessica and Tyrtova, Evgeniya and Zhao, Zirun and III, Norman Garrett and Peterson, Racheal and Zada, Gabriel and Emerson, Samuel and Ferreira, Manuel and Ruzevick, Jacob},
  title = {Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Corticotroph Pituitary Neuroendocrine Tumors},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779925}
}
Kostenlos starten →